Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenfeng Wang

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Oncoimmunology|January 13, 2022
Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunityHanfeng Wang, Yang Fan, Weihao Chen, et al.
Nature Communications|March 31, 2026
PD-1 blockade plus tyrosine kinase inhibitor remodels the tumor microenvironment in advanced renal cell carcinomaLiangyou Gu, Qi Zhang, Qiyang Liang, et al.
Discover Oncology|October 31, 2024
ATF4/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinomaYongliang Lu, Weihao Chen, Yundong Xuan, et al.
Cancer Letters|May 21, 2021
E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesisDonglai Shen, Yu Gao, Qingbo Huang, et al.
Urologic Oncology|March 8, 2021
Prognostic role of bland thrombus in patients treated with resection of renal cell carcinoma with inferior vena cava tumor thrombusHanfeng Wang, Xintao Li, Qingbo Huang, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Oncoimmunology|January 13, 2022
Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunityHanfeng Wang, Yang Fan, Weihao Chen, et al.
Nature Communications|March 31, 2026
PD-1 blockade plus tyrosine kinase inhibitor remodels the tumor microenvironment in advanced renal cell carcinomaLiangyou Gu, Qi Zhang, Qiyang Liang, et al.
Discover Oncology|October 31, 2024
ATF4/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinomaYongliang Lu, Weihao Chen, Yundong Xuan, et al.
Cancer Letters|May 21, 2021
E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesisDonglai Shen, Yu Gao, Qingbo Huang, et al.
Urologic Oncology|March 8, 2021
Prognostic role of bland thrombus in patients treated with resection of renal cell carcinoma with inferior vena cava tumor thrombusHanfeng Wang, Xintao Li, Qingbo Huang, et al.
Pageof 6